Follow
Ragunath Singaravelu
Ragunath Singaravelu
Ottawa Hospital Research Institute
Verified email at toh.ca
Title
Cited by
Cited by
Year
Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy
JP Pezacki, JA Blake, DC Danielson, DC Kennedy, RK Lyn, ...
Nature chemical biology 7 (3), 137-145, 2011
2452011
microRNA-33 regulates macrophage autophagy in atherosclerosis
M Ouimet, H Ediriweera, MS Afonso, B Ramkhelawon, R Singaravelu, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 37 (6), 1058-1067, 2017
1782017
Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti-miR33 in atherosclerosis
D Karunakaran, AB Thrush, MA Nguyen, L Richards, M Geoffrion, ...
Circulation research 117 (3), 266-278, 2015
1742015
Hepatitis C virus induced up‐regulation of microRNA‐27: A novel mechanism for hepatic steatosis
R Singaravelu, R Chen, RK Lyn, DM Jones, S O'Hara, Y Rouleau, ...
Hepatology 59 (1), 98-108, 2014
1172014
MicroRNAs regulate the immunometabolic response to viral infection in the liver
R Singaravelu, S O'hara, DM Jones, R Chen, NG Taylor, P Srinivasan, ...
Nature chemical biology 11 (12), 988-993, 2015
672015
Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes
RK Lyn, R Singaravelu, S Kargman, S O'Hara, H Chan, R Oballa, ...
Scientific Reports 4 (1), 4549, 2014
672014
An enzyme-linked assay for the rapid quantification of microRNAs based on the viral suppressor of RNA silencing protein p19
N Nasheri, J Cheng, R Singaravelu, P Wu, MT McDermott, JP Pezacki
Analytical biochemistry 412 (2), 165-172, 2011
542011
Competing roles of microRNA-122 recognition elements in hepatitis C virus RNA
N Nasheri, R Singaravelu, M Goodmurphy, RK Lyn, JP Pezacki
Virology 410 (2), 336-344, 2011
532011
Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe
R Singaravelu, DR Blais, CS McKay, JP Pezacki
Proteome science 8, 1-15, 2010
462010
Hepatitis C virus and microRNAs: miRed in a host of possibilities
R Singaravelu, RS Russell, DL Tyrrell, JP Pezacki
Current opinion in virology 7, 1-10, 2014
372014
Characterization of critical determinants of ACE2–SARS CoV-2 RBD interaction
EEF Brown, R Rezaei, TR Jamieson, J Dave, NT Martin, R Singaravelu, ...
International Journal of Molecular Sciences 22 (5), 2268, 2021
352021
Fluorescence lifetime imaging of alterations to cellular metabolism by domain 2 of the hepatitis C virus core protein
N Mazumder, RK Lyn, R Singaravelu, A Ridsdale, DJ Moffatt, CW Hu, ...
PLoS one 8 (6), e66738, 2013
342013
Host–virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem
JP Pezacki, R Singaravelu, RK Lyn
Molecular BioSystems 6 (7), 1131-1142, 2010
342010
MicroRNA-7 mediates cross-talk between metabolic signaling pathways in the liver
R Singaravelu, C Quan, MH Powdrill, TA Shaw, P Srinivasan, RK Lyn, ...
Scientific Reports 8 (1), 361, 2018
312018
Human serum activates CIDEB-mediated lipid droplet enlargement in hepatoma cells
R Singaravelu, RK Lyn, P Srinivasan, J Delcorde, RH Steenbergen, ...
Biochemical and Biophysical Research Communications 441 (2), 447-452, 2013
312013
Concise review: targeting cancer stem cells and their supporting niche using oncolytic viruses
MJF Crupi, JC Bell, R Singaravelu
Stem Cells 37 (6), 716-723, 2019
272019
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
T Azad, R Singaravelu, Z Taha, TR Jamieson, S Boulton, MJF Crupi, ...
Molecular Therapy 29 (6), 1984-2000, 2021
262021
SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition
T Azad, R Singaravelu, EEF Fekete, Z Taha, R Rezaei, R Arulanandam, ...
Biosensors and Bioelectronics 180, 113122, 2021
252021
Deletion of apoptosis inhibitor F1L in vaccinia virus increases safety and oncolysis for cancer therapy
A Pelin, J Foloppe, J Petryk, R Singaravelu, M Hussein, F Gossart, ...
Molecular Therapy-Oncolytics 14, 246-252, 2019
252019
Implications for SARS-CoV-2 vaccine design: Fusion of spike glycoprotein transmembrane domain to receptor-binding domain induces trimerization
T Azad, R Singaravelu, MJF Crupi, T Jamieson, J Dave, EEF Brown, ...
Membranes 10 (9), 215, 2020
242020
The system can't perform the operation now. Try again later.
Articles 1–20